All Categories
Quality Control of Plasmid DNA

Quality Control of Plasmid DNA

Home >  Microbial CDMO  >  Analysis and Testing  >  Quality Control  >  Quality Control of Plasmid DNA

Quality Control of Plasmid DNA

Yaohai Bio-Pharma has been involved in the Plasmid DNA (pDNA) quality control (QC) and batch release for different uses, e.g., naked plasmid, DNA vaccines, and pDNA as raw materials for virus-vectored therapy or mRNA.

We design QC Testing for appearance, identification, activity, purity, and impurities, following ICH Quality guidelines, relevant Pharmacopoeia (EU and US monographs), regulatory guidelines (ICH, FDA, and EMA), and GMP/GLP practices.

Service Details
Category Quality Attributes Analytical Techniques
Raw materials, excipients All or Critical parameters of raw materials and excipients By validated analytical techniques (third party).
Packaging materials Thorough testing By validated analytical techniques (third party).
Physicochemical property Appearance, visible foreign material Visual
Insoluble particles Light obscuration
Particle diameter Zeta potential
pH Potential
Total organic carbon (TOC) Ultraviolet (UV)
Electrical conductivity Electrode
Osmolality Freezing point titration
Moisture content Titration
Loss on drying Atmospheric pressure, Vacuum drying
Residue on ignition Ignition
Deliverable volume Volumetric, gravimetric
Biochemical property DNA concentration UV
Identity Target gene sequencing Sequence alignment (third party)
Whole plasmid sequencing
Whole genome sequencing
Restriction enzymes digestion Agarose Gel Electrophoresis (AGE)
Product-related impurities Superhelix plasmid purity or linear plasmid purity AGE, High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE)
Process-related impurities Residual endotoxin Gel method, chromogenic method
Host cell protein, HCP Enzyme-linked Immunosorbent Assay (ELISA)
Host cell DNA -HCD Quantitative Polymerase Chain Reaction (qPCR)
Host RNA Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR)
Residual antibiotic ELISA
Bioburden Bioburden Plate counting, membrane filtration
Sterility Direct inoculation, membrane filtration
Stability studies Accelerated stability High-temperature, Photostability, Repeated freeze-thaw test
Long-term stability NA
Our Experiences

Yaohai Bio-pharma has experience working with many classes of large molecules including but not limited to:

Naked plasmid for gene therapy, e.g., Vascular Endothelial Growth Factor (VEGF), Hepatocyte Growth Factor (HGF), Stromal Cell-derived Factor 1 (SDF-1).

DNA vaccine for infectious disease prevention or cancer therapy.

Plasmid DNA as materials for Adeno-Associated Virus (AAV) or mRNA production.

Get a Free Quote

Get in touch